Though UnitedHealth reported disappointing first-quarter results last week, two analysts from KeyBanc Capital Markets and Truist Securities remain bullish on the stock.
Latest Ratings for UNH
DateFirmActionFromTo Jan 2022SVB LeerinkMaintainsOutperform Jan 2022BMO CapitalMaintainsMarket Perform Jan 2022Raymond JamesMaintainsStrong Buy